Literature DB >> 17609366

Peripheral deletion of mature alloreactive B cells induced by costimulation blockade.

Yijin Li1, Lianli Ma, Jikun Shen, Anita S Chong.   

Abstract

Alloreactive B cells can contribute to graft rejection. Anti-CD154 treatment together with donor-specific transfusion (DST) results in the long-term survival of MHC-mismatched mouse heart grafts and inhibition of alloantibody production. To characterize the mechanism of B cell tolerance induced by the anti-CD154 and DST, we used 3-83Igi mice, on BALB/c (H-2K(d)) background, that express a B cell receptor that reacts with MHC class I antigens H-2K(b). Transplanting C57BL/6 (H-2K(b)) hearts into 3-83Igi mice, followed by tolerance induction, resulted in the peripheral deletion of mature but not immature 3-83 B cells. The sustained deletion of mature alloreactive B cells required the presence of the allograft and can be explained by the absence of T cell help.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609366      PMCID: PMC1924566          DOI: 10.1073/pnas.0705240104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand.

Authors:  T G Markees; N E Phillips; R J Noelle; L D Shultz; J P Mordes; D L Greiner; A A Rossini
Journal:  Transplantation       Date:  1997-07-27       Impact factor: 4.939

2.  Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification.

Authors:  R Pelanda; S Schwers; E Sonoda; R M Torres; D Nemazee; K Rajewsky
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

3.  Self-reactive B cells are not eliminated or inactivated by autoantigen expressed on thyroid epithelial cells.

Authors:  S Akkaraju; K Canaan; C C Goodnow
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

Review 4.  Immunological strategies targeting B cells in organ grafting.

Authors:  Renaud Snanoudj; Séverine Beaudreuil; Nadia Arzouk; Hélène de Preneuf; Antoine Durrbach; Bernard Charpentier
Journal:  Transplantation       Date:  2005-02-15       Impact factor: 4.939

Review 5.  The role of gp39 (CD40L) in immunity.

Authors:  R J Noelle
Journal:  Clin Immunol Immunopathol       Date:  1995-09

6.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

Review 7.  Tolerance sensitivity of immature-stage B cells: can developmentally regulated B cell antigen receptor (BCR) signal transduction play a role?

Authors:  J G Monroe
Journal:  J Immunol       Date:  1996-04-15       Impact factor: 5.422

8.  Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand.

Authors:  D C Parker; D L Greiner; N E Phillips; M C Appel; A W Steele; F H Durie; R J Noelle; J P Mordes; A A Rossini
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

9.  The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help.

Authors:  D A Fulcher; A B Lyons; S L Korn; M C Cook; C Koleda; C Parish; B Fazekas de St Groth; A Basten
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

10.  Transitional B cells are the target of negative selection in the B cell compartment.

Authors:  R Carsetti; G Köhler; M C Lamers
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more
  14 in total

1.  Long-term control of alloreactive B cell responses by the suppression of T cell help.

Authors:  Yijin Li; Lianli Ma; Dengping Yin; JiKun Shen; Anita S Chong
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

2.  Siglecs induce tolerance to cell surface antigens by BIM-dependent deletion of the antigen-reactive B cells.

Authors:  Matthew S Macauley; James C Paulson
Journal:  J Immunol       Date:  2014-09-24       Impact factor: 5.422

Review 3.  Essential role for B cells in transplantation tolerance.

Authors:  Robert R Redfield; Eduardo Rodriguez; Ronald Parsons; Kumar Vivek; Moiz M Mustafa; Hooman Noorchashm; Ali Naji
Journal:  Curr Opin Immunol       Date:  2011-10       Impact factor: 7.486

4.  The contribution of B cells to transplantation tolerance.

Authors:  Luis Graca
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

5.  Transplantation tolerance modifies donor-specific B cell fate to suppress de novo alloreactive B cells.

Authors:  Stella Hw Khiew; Dharmendra Jain; Jianjun Chen; Jinghui Yang; Dengping Yin; James S Young; Alexander Dent; Roger Sciammas; Maria-Luisa Alegre; Anita S Chong
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 6.  Experimental models of B cell tolerance in transplantation.

Authors:  Michelle L Cowan; Roger Sciammas; Anita S Chong
Journal:  Semin Immunol       Date:  2011-09-16       Impact factor: 11.130

Review 7.  Transplantation tolerance: don't forget about the B cells.

Authors:  A S Chong; S H Khiew
Journal:  Clin Exp Immunol       Date:  2017-02-28       Impact factor: 4.330

8.  Blockade of both B7-H4 and CTLA-4 co-signaling pathways enhances mouse islet allograft survival.

Authors:  Xiaojie Wang; Jianqiang Hao; Daniel L Metzger; Alice Mui; I-Fang Lee; Noushin Akhoundsadegh; C Lieping Chen; Dawei Ou; Ziliang Ao; C Bruce Verchere; Garth L Warnock
Journal:  Islets       Date:  2012-07-01       Impact factor: 2.694

Review 9.  Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism.

Authors:  Carrie Gibbons; Megan Sykes
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

Review 10.  Transplantation tolerance and its outcome during infections and inflammation.

Authors:  Anita S Chong; Maria-Luisa Alegre
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.